Advanced glycation end products as biomarkers in systemic diseases: premises and perspectives of salivary advanced glycation end products

Biomark Med. 2019 Apr;13(6):479-495. doi: 10.2217/bmm-2018-0448. Epub 2019 Apr 10.

Abstract

Advanced glycation end products (AGEs) are glycated proteins associated with high dry temperature food processing, coloring and flavor modification of food products. Previous studies on diet-related disease support the role of the glycation products as biomarkers in local and general proinflammatory response. Exogenous and endogenous AGEs are involved in chronic low-level inflammation, which underlies the onset of metabolic syndrome influenced by food intake, there by demonstrating their implication in diet-related pathologies. Although studies have revealed a strong association between the accumulation of AGEs and the occurrence/worsening of metabolic diseases, their routine use for the diagnosis or monitoring of local and general disease has not yet been reported.

Keywords: AGEs; AGEs diagnosis and downregulation; advanced glycation end products; biomarkers; biosensor; chronic low-level inflammation; diet-related disease; metabolic syndrome; metainflammation; saliva.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / metabolism
  • Animals
  • Biomarkers / chemistry
  • Biomarkers / metabolism
  • Disease*
  • Glycation End Products, Advanced / chemistry
  • Glycation End Products, Advanced / metabolism*
  • Humans
  • Saliva / metabolism*

Substances

  • Biomarkers
  • Glycation End Products, Advanced